Clobazam
Brand name: Clobazam
Rank #425 of 500 drugs by total cost
$19.8M
Total Cost
58,877
Total Claims
$19.8M
Total Cost
1,591
Prescribers
$336
Cost per Claim
5,167
Beneficiaries
69,293
30-Day Fills
$12K
Avg Cost/Provider
37
Avg Claims/Provider
About Clobazam
Clobazam (sold as Clobazam) was prescribed 58,877 times by 1,591 Medicare Part D providers in 2023, costing the program $19.8M. At $336 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 422 | Efinaconazole (Jublia) | $20.4M | 15,425 |
| 423 | Mometasone/Formoterol (Dulera) | $20.4M | 46,961 |
| 424 | Brinzolamide (Azopt) | $20.1M | 57,322 |
| 425 | Clobazam (Clobazam) | $19.8M | 58,877 |
| 426 | Fluorouracil (Fluorouracil) | $19.5M | 220,445 |
| 427 | Ertapenem Sodium (Ertapenem) | $19.4M | 36,784 |
| 428 | Sumatriptan Succinate (Sumatriptan Succinate) | $19.4M | 555,011 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology